4.7 Article

Exploring the contribution of estrogen to amyloid-beta regulation: a novel multifactorial computational modeling approach

Journal

FRONTIERS IN PHARMACOLOGY
Volume 4, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2013.00016

Keywords

Alzheimer disease; amyloid-beta; estrogen; computational model; declarative programming; formal methods; multifactorial process; multi-drug therapy

Ask authors/readers for more resources

According to the amyloid hypothesis, Alzheimer Disease results from the accumulation beyond normative levels of the peptide amyloid-beta (A beta). Perhaps because of its pathological potential, A beta and the enzymes that produce it are heavily regulated by the molecular interactions occurring within cells, including neurons. This regulation involves a highly complex system of intertwined normative and pathological processes, and the sex hormone estrogen contributes to it by influencing the A beta-regulation system at many different points. Owing to its high complexity, A beta-regulation and the contribution of estrogen are very difficult to reason about. This report describes a computational model of the contribution of estrogen to A beta-regulation that provides new insights and generates experimentally testable and therapeutically relevant predictions. The computational model is written in the declarative programming language known as Maude, which allows not only simulation but also analysis of the system using temporal-logic. The model illustrates how the various effects of estrogen could work together to reduce A beta levels, or prevent them from rising, in the presence of pathological triggers. The model predicts that estrogen itself should be more effective in reducing A beta than agonists of estrogen receptor alpha (ER alpha), and that agonists of ER beta should be ineffective. The model shows how estrogen itself could dramatically reduce A beta, and predicts that non-steroidal anti-inflammatory drugs should provide a small additional benefit. It also predicts that certain compounds, but not others, could augment the reduction in A beta due to estrogen. The model is intended as a starting point for a computational/experimental interaction in which model predictions are tested experimentally, the results are used to confirm, correct, and expand the model, new predictions are generated, and the process continues, producing a model of ever increasing explanatory power and predictive value.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available